SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600132-22-000013
Filing Date
2022-04-25
Accepted
2022-04-25 08:25:17
Documents
7
Period of Report
2022-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A blph-20220425xdef14a.htm DEF 14A 586632
2 GRAPHIC blph-20220425xdef14a001.jpg GRAPHIC 9614
3 GRAPHIC blph-20220425xdef14a002.jpg GRAPHIC 5781
4 GRAPHIC blph-20220425xdef14a003.jpg GRAPHIC 8853
5 GRAPHIC blph-20220425xdef14a004.jpg GRAPHIC 5001
6 GRAPHIC blph-20220425xdef14a011.jpg GRAPHIC 224596
7 GRAPHIC blph-20220425xdef14a012.jpg GRAPHIC 185097
  Complete submission text file 0001600132-22-000013.txt   1193184
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 22847422
SIC: 2834 Pharmaceutical Preparations